These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33575113)

  • 1. Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes.
    Zhao H; Liu X; Yu L; Lin S; Zhang C; Xu H; Leng Z; Huang W; Lei J; Li T; Li J; Yang F; Wang L
    Mol Ther Nucleic Acids; 2021 Mar; 23():667-681. PubMed ID: 33575113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
    Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
    Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis.
    Xie N; Zhang R; Bi Z; Ren W; You K; Hu H; Xu Y; Yao H
    Cell Oncol (Dordr); 2023 Apr; 46(2):375-390. PubMed ID: 36576700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia.
    James AR; Schroeder MP; Neumann M; Bastian L; Eckert C; Gökbuget N; Tanchez JO; Schlee C; Isaakidis K; Schwartz S; Burmeister T; von Stackelberg A; Rieger MA; Göllner S; Horstman M; Schrappe M; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Akalin A; Baldus CD
    J Hematol Oncol; 2019 Jan; 12(1):8. PubMed ID: 30642353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of lncRNA
    Yang F; Lv SX; Lv L; Liu YH; Dong SY; Yao ZH; Dai XX; Zhang XH; Wang OC
    Onco Targets Ther; 2016; 9():7039-7045. PubMed ID: 27895496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype.
    Cedro-Tanda A; Ríos-Romero M; Romero-Córdoba S; Cisneros-Villanueva M; Rebollar-Vega RG; Alfaro-Ruiz LA; Jiménez-Morales S; Domínguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Bautista-Piña V; Beltrán-Anaya FO; Hidalgo-Miranda A
    Sci Rep; 2020 Aug; 10(1):13146. PubMed ID: 32753692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis.
    Li XX; Wang LJ; Hou J; Liu HY; Wang R; Wang C; Xie WH
    Biomed Res Int; 2020; 2020():8970340. PubMed ID: 32190687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data.
    Zhao H; Zhang S; Yin X; Zhang C; Wang L; Liu K; Xu H; Liu W; Bo L; Lin S; Feng K; Lin L; Fei M; Ning S; Wang L
    Front Immunol; 2022; 13():990143. PubMed ID: 36304471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
    Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
    Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.
    Li Y; Li S; Chen J; Shao T; Jiang C; Wang Y; Chen H; Xu J; Li X
    Hum Mol Genet; 2014 Oct; 23(20):5378-93. PubMed ID: 24871326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovering DNA methylation patterns for long non-coding RNAs associated with cancer subtypes.
    Ma X; Yu L; Wang P; Yang X
    Comput Biol Chem; 2017 Aug; 69():164-170. PubMed ID: 28501295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes.
    Su X; Malouf GG; Chen Y; Zhang J; Yao H; Valero V; Weinstein JN; Spano JP; Meric-Bernstam F; Khayat D; Esteva FJ
    Oncotarget; 2014 Oct; 5(20):9864-76. PubMed ID: 25296969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetically regulated lncRNAs dissect the intratumoural heterogeneity and facilitate immune evasion of glioblastomas.
    Xu D; Cao M; Wang B; Bi X; Zhang H; Wu D; Zhang C; Xu J; Xu Z; Zheng D; Chen L; Li P; Wang H; Liu Y; Jiang H; Li K
    Theranostics; 2023; 13(5):1490-1505. PubMed ID: 37056564
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrative Analysis of the Doxorubicin-Associated LncRNA-mRNA Network Identifies Chemoresistance-Associated lnc-TRDMT1-5 as a Biomarker of Breast Cancer Progression.
    Chen Q; Yang H; Zhu X; Xiong S; Chi H; Xu W
    Front Genet; 2020; 11():566. PubMed ID: 32547604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Two Molecular Subtypes of Hepatocellular Carcinoma Based on Dysregulated Immune LncRNAs.
    Lin H; Xie Y; Kong Y; Yang L; Li M
    Front Mol Biosci; 2021; 8():625858. PubMed ID: 34888348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic long noncoding RNA landscape in breast cancer.
    Xu S; Kong D; Chen Q; Ping Y; Pang D
    Mol Cancer; 2017 Jul; 16(1):129. PubMed ID: 28738804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative Analysis of DNA Methylation Data and Transcriptome Data Identified a DNA Methylation-Dysregulated Four-LncRNA Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma.
    Wang Q; Yang W; Peng W; Qian X; Zhang M; Wang T
    Front Cell Dev Biol; 2021; 9():666349. PubMed ID: 33869232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Pan-Central Nervous System Tumor Methylome Analyses Reveal Immune-Related LncRNAs.
    Li Y; Xu S; Xu D; Pan T; Guo J; Gu S; Lin Q; Li X; Li K; Xiang W
    Front Immunol; 2022; 13():853904. PubMed ID: 35603200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective expression of long non-coding RNAs in a breast cancer cell progression model.
    Tracy KM; Tye CE; Page NA; Fritz AJ; Stein JL; Lian JB; Stein GS
    J Cell Physiol; 2018 Feb; 233(2):1291-1299. PubMed ID: 28488769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profile analysis of long noncoding RNA in HER-2-enriched subtype breast cancer by next-generation sequencing and bioinformatics.
    Yang F; Lyu S; Dong S; Liu Y; Zhang X; Wang O
    Onco Targets Ther; 2016; 9():761-72. PubMed ID: 26929647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.